Background: In vertebrobasilar ischemic stroke, magnetic resonance angiography (MRA) occasionally fails to visualize the basilar artery, but in these patients, little attention has been given to establishing correlations between the clinical and the radiological findings. Our aim was to identify clinical or radiological measures that could assist in predicting a favorable clinical outcome. Methods: Risk factors, clinicoradiological features, and functional outcomes were assessed in 40 patients with vertebrobasilar ischemic stroke whose basilar arteries were absent on MRA. The presence of potential feeding arteries to the posterior circulation was recorded from a review of the MRA data. To permit quantitative analysis of the images, a potential feeding artery score (PFAS; range: 0–8) was established. One point was assigned when a signal was seen from an intracranial vertebral artery, a posterior inferior cerebellar artery, a superior cerebellar artery, or a posterior cerebral artery. On MRI, the location of the infarction was classified as involving the proximal, middle, and distal territories of the intracranial posterior circulation. The infarctions were also categorized as single- or multi-sector infarctions, and according to whether more than one penetrating or branch artery was involved. Clinical outcomes were classified as favorable (modified Rankin Scale = 0–2) or poor (modified Rankin Scale = 3–6). Results: The clinical outcome was favorable in 30% (n = 12) of patients, and poor in 70% (n = 28). A transient ischemic attack preceded the stroke in 48% of patients, especially those with a favorable outcome (67%). Patients with a favorable outcome had a higher PFAS (p = 0.036) and an increased incidence of single-sector infarction (p = 0.049). Conclusions: Our study suggests that a higher PFAS, accompanied by a single-sector infarction, is a predictor of improved clinical outcome in patients with vertebrobasilar ischemic stroke in which the basilar artery was absent on MRA.

Keywords:
Vertebrobasilar ischemic stroke, Basilar artery, Magnetic resonance angiography
1.
Kubik CS, Adams RD: Occlusion of the basilar artery: A clinical and pathological study. Brain 1946;69:73–121.
2.
Archer CR, Horenstein S: Basilar artery occlusion: Clinical and radiological correlation. Stroke 1977;8:383–390.
3.
Fisher CM: The ‘herald hemiparesis’ of basilar artery occlusion. Arch Neurol 1988;45:1301–1303.
4.
Ferbert A, Bruckmann H, Drummen R: Clinical features of proven basilar artery occlusion. Stroke 1990;21:1135–1142.
5.
Caplan LR: Occlusion of the vertebral or basilar artery: Follow-up analysis of some patients with benign outcome. Stroke 1979;10:277–282.
6.
Fields WS, Ratinov G, Weibel J, Campos RJ: Survival following basilar artery occlusion. Arch Neurol 1966;15:463–471.
7.
Knepper L, Biller J, Adams HP, Yuh W, Ryals T, Godersky J: MR imaging of basilar artery occlusion. J Comput Assist Tomogr 1990;14:32–35.
8.
Castillo M, Falcone S, Naidich TP, Bowen B, Quencer RM: Imaging in acute basilar artery thrombosis. Neuroradiology 1994;36:426–429.
9.
Caplan L: Posterior circulation ischemia: Then, now, and tomorrow. Stroke 2000;31:2011–2023.
10.
Foix C, Hillemand P: Note sur la disposition générale des artères de l’axe encéphalique. CR Soc Biol 1925;92:31–33.
11.
Oppenheim C, Stanescu R, Dormont D, et al: False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol 2000;21:1434–1440.
12.
Patrick BK, Ramirez-Lassepas M, Snyder BD: Temporal profile of vertebrobasilar territory infarction: Prognostic implications. Stroke 1980;11:643–648.
13.
Caplan LR, Rosenbaum AE: Role of cerebral angiography in vertebrobasilar occlusive disease. J Neurol Neurosurg Psychiatry 1975;38:601–612.
14.
Caplan LR: ‘Top of the basilar’ syndrome. Neurology 1980;30:72–79.
15.
Sato M, Tanaka S, Kohama A: ‘Top of the basilar’ syndrome: Clinico-radiological evaluation. Neuroradiology 1987;29:354–359.
16.
Jones HR, Millikan CH, Sandok BA: Temporal profile (clinical course) of acute vertebrobasilar system cerebral infarction. Stroke 1980;11:173–177.
17.
Nadeau S, Jordan J, Mishra S: Clinical presentation as a guide to early prognosis in vertebrobasilar stroke. Stroke 1992;23:165–170.
18.
Brown RD Jr, Petty GW, O’Fallon WM, Wiebers DO, Whisnant JP: Incidence of transient ischemic attack in Rochester, Minnesota, 1985–1989. Stroke 1998;29:2109–2113.
19.
Donnan GA, O’Malley HM, Quang L, Hurley S, Bladin PF: The capsular warning syndrome: Pathogenesis and clinical features. Neurology 1993;43:957–962.
20.
Shin HK, Yoo KM, Chang HM, Caplan LR: Bilateral intracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1999;56:1353–1358.
21.
Appelros P, Nydevik I, Viitanen M: Poor outcome after first-ever stroke. Stroke 2003;34:122–126.
22.
Chen J, Simon R: Ischemic tolerance in the brain. Neurology 1997;48:306–311.
23.
Weih M, Kallenberg K, Bergk A, et al: Attenuated stroke severity after prodromal TIA: A role for ischemic tolerance in the brain? Stroke 1999;30:1851–1854.
24.
du Mesnil de Rochemont R, Neumann-Haefelin T, Berkefeld J, Sitzer M, Lanfermann H: Magnetic resonance imaging in basilar artery occlusion. Arch Neurol 2002;59:398–402.
25.
Brandt T, Pessin MS, Kwan ES, Caplan LR: Survival with basilar artery occlusion. Cerebrovasc Dis 1995;5:182–187.
26.
Marinkovic S, Milisavljevic M, Kovacevic M: Interpeduncular perforating branches of the posterior cerebral artery. Surg Neurol 1986;26:349–359.
27.
Brandt T, Steinke W, Thie A, Pessin MS, Caplan LR: Posterior cerebral artery territory infarcts: Clinical features, infarct topography, causes and outcome. Cerebrovasc Dis 2000;10:170–182.
28.
Eckert B, Koch C, Thomalla G, Roether J, Zeumer H: Acute basilar artery occlusion treated with combined intravenous abciximab and intra-arterial tissue plasminogen activator. Stroke 2002;33:1424–1427.
29.
Mayer TE, Hamann GF, Brueckmann HJ: Treatment of basilar artery embolism with a mechanical extraction device. Stroke 2002;33:2232–2235.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.